Here is another piece of the "evolution" puzzle from a news release from John Hopkins Kimmel Cancer Center when its "Kimmel wire" email news service sent me this excerpt yesterday:
[quote]Targeted cancer cell therapies using man-made proteins dramatically shrink many tumors in the first few months of treatment, but new research from Johns Hopkins scientists finds why the cells all too often become resistant, the treatment stops working, and the disease returns.
[/quote]
As you can see from the full news release, it is about colon cancer and there is no proof that it would apply to oral cancer- I want to make that clear - although I do believe it does raise a hypothesis worth exploring for oral cancer patients. Hopkins news release
As noted in this thread, right now using a combination of therapies looks promising.
charm